Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

128
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
128
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

215
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
215
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

163
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
163
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

291
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
291
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

208
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
208
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

102
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
102

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achieving optimal uptake of TB preventive treatment for rifampin-resistant and/or multidrug-resistant TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial.

The Journal of infectious diseases·2025
Same author

Evaluation of treatment outcomes and associated risk factors in children with TB in Bangladesh.

Public health action·2025
Same author

Application of a TB care cascade to a novel household contact intervention in rural South Africa.

Public health action·2024
Same author

TB disease yield from household contact screening of TB index patients in Pakistan.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024
Same author

Effect of various antioxidants on ovarian tissue vitrification success in sheep.

Cryo letters·2024

Related Experiment Video

Updated: May 24, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K

TB yields from expanded contact tracing investigations.

A Madan1, A A Malik2,3, M B Brooks1

  • 1Boston University School of Public Health, Boston, MA, USA.

Public Health Action
|March 3, 2025
PubMed
Summary

Expanding tuberculosis (TB) contact tracing to pediatric, clinically diagnosed, and extrapulmonary cases can significantly improve case detection. This inclusive strategy enhances TB control efforts and moves closer to global TB elimination goals.

Keywords:
extrapulmonary TBpediatric TBsmear-negative TB

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

Related Experiment Videos

Last Updated: May 24, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Global Health

Background:

  • Tuberculosis (TB) presents a major global health challenge, exacerbated by a significant gap in case detection.
  • Current contact tracing strategies predominantly focus on bacteriologically confirmed pulmonary TB, often neglecting pediatric, clinically diagnosed, and extrapulmonary TB cases.

Purpose of the Study:

  • To assess the potential of broadening contact tracing efforts to include pediatric, clinically diagnosed, and extrapulmonary TB index patients.
  • To evaluate the yield of contact tracing in these frequently overlooked TB subgroups.

Main Methods:

  • A targeted literature review was performed using major scientific databases (PubMed, Web of Science, Google Scholar, Lens.org).
  • Inclusion and exclusion criteria were applied to a title and abstract review of identified studies.

Main Results:

  • Thirteen studies reported contact tracing yields from the targeted index patient groups.
  • Yields for active TB disease were up to 8.1% (pediatric), 3.0% (clinically diagnosed), and 2.1% (extrapulmonary).
  • Yields for TB infection were up to 17.9% (pediatric), 12.6% (clinically diagnosed), and 11.1% (extrapulmonary).

Conclusions:

  • Expanding contact tracing to include these typically excluded TB cases can substantially improve case detection rates.
  • Refining contact tracing protocols and implementing inclusive strategies are crucial for enhancing TB control and achieving global elimination targets.